Trial intelligence / Profile preview

Optimization of platelet-rich plasma treatment for chronic patellar tendinopathy (jumper's knee)

2010-021957-38Phase 4Completed

Sponsor
Centre Hospitalier Universitaire de Liège
Start
Jul 2010
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of platelet-rich plasma in Patellar Tendinitis (PT), sponsored by Centre Hospitalier Universitaire de Liège. Primary endpoints: Standardization of PRP treatment for chronic tendinopathy and Pain reduction after PRP injection. Started Jul 2010; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

Patellar Tendinitis (PT)

Beyond the preview

Go deeper on 2010-021957-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-021957-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call